FDA Orange Book · active-ingredient family
Norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride
Norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:RAVOCAINE AND NOVOCAIN W/ LEVOPHED · NDA 008592
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| RAVOCAINE AND NOVOCAIN W/ LEVOPHED | EASTMAN KODAK | NDA 008592 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
